Welcome!

News Feed Item

Nutricia Launches Breakthrough Once-a-Day Drink for People with Early Alzheimer's Disease

LONDON, January 14, 2013 /PRNewswire/ --

Souvenaid, a "Food for Special Medical Purposes" for the dietary management of early Alzheimer's disease

From today, Souvenaid, a unique 125ml once-a-day drink, is available for people living with early Alzheimer's disease. This over-the-counter innovative product is the result of over 10 years' research into the nutritional needs of people living with the early stages of the disease.

     (Logo: http://photos.prnewswire.com/prnh/20130113/588426 )

Around 800,000 people in the UK live with dementia,1 of which Alzheimer's disease is the most common form. It is a growing health problem in an aging population, leading the government to prioritise earlier diagnosis of the condition.

The loss of connections in the brain (synapses) is one of the key features of early Alzheimer's disease. A combination of nutrients are required in the process of making new connections and people living with Alzheimer's disease have been shown to have relatively low levels of these nutrients in their bodies despite eating a normal diet.2,3,4,5,6,7

This adds to a growing body of evidence that highlights how nutrition can help manage the disease in the early stages.8,9,10,11,12,13

Dr David Wilkinson, Consultant in Old Age Psychiatry, commented: "Alzheimer's disease is not part and parcel of aging but a serious and progressive disease of the brain which prevents us from being able to retain new memories. As we age, our bodies become less efficient at processing essential nutrients, meaning that we need to increase our intake of food to absorb the same amount of nutrients in order to maintain a healthy body. In the same way, we need the right nutrients for our brains to keep them healthy.

"Alzheimer's disease sufferers often find it very difficult to get everything they need through diet alone and the nutritional intervention by the use of Souvenaid is a new area of research offering promising results for the management of early Alzheimer's disease."

The current healthcare provision for people with early Alzheimer's disease fails to reflect the important role that nutrition can play in managing the disease. A recent survey of specialists involved in the diagnosis of Alzheimer's disease showed that only a third (33%) regularly assess patients' nutritional status during the diagnostic process.14 Two-thirds of specialists do not even have access to a dietician for these patients.14

Often, after a diagnosis of Alzheimer's disease, it can be difficult to stay positive, particularly when there is little to offer in the way of effective early interventions. Souvenaid offers a new option for people living with early-stage Alzheimer's disease.

Barbara Stephens, Dementia UK Chief Executive, commented: "A diagnosis of dementia is devastating both for those with the condition and their families and carers. Early-stage intervention is important for maximising choices and enabling people with dementia and their carers to lead healthier lives for longer." 

Souvenaid contains a unique combination of nutrients that are naturally present in food, at levels difficult to achieve from diet alone. It contains: omega-3 polyunsaturated fatty acids (docosahexaenoic acid (DHA), eicosapentaenoic acid [EPA]), uridine (as uridine monophosphate [UMP]) and choline, together with phospholipids and B vitamins. Souvenaid comes in two tasty flavours (vanilla and strawberry) and tastes best served chilled. Souvenaid is designed to be incorporated into the daily routine, for example, by taking it at breakfast time.

Souvenaid is a Food for Special Medical Purposes, for the dietary management of early Alzheimer's disease. It is available over-the-counter from local accredited pharmacists. People with early Alzheimer's disease must speak with a doctor, specialist nurse, dietician or pharmacist to see if Souvenaid is right for them.

Please visit http://www.souvenaid.com for more information.

Notes to Editors

About Nutricia Advanced Medical Nutrition

  • Nutricia is the leading medical nutrition company in Europe. It is part of Danone, one of the fastest-growing food and nutrition companies in the world.
  • Nutricia aims to bring health through medical nutrition to those people who most need it, focusing on people with disease- or age-related nutritional needs.
  • Nutricia has an extensive portfolio of products and services, catering from nutritional needs in metabolic conditions such as phenylketonuria (PKU), to non-metabolic conditions such as allergy and epilepsy, to disease-related malnutrition and frailty.
  • Through its Homeward service and 100 dedicated nurses, Nutricia supports over 20,000 people in the UK who require enteral nutrition (tube feeding) support in their own homes.

http://www.nutricia.com

About Souvenaid

Souvenaid is:

  • Designed to be taken daily.
  • A 125ml daily drink, available in two tasty flavours, vanilla and strawberry.
  • A food for special medical purposes and must be used under medical supervision.
  • Available from 14th January 2013 in accredited pharmacies in England, Wales and Scotland, and via http://www.souvenaid.com.
  • Gluten and lactose free.

Souvenaid contains:

  • A unique combination of nutrients including omega-3 polyunsaturated fatty acids (docosahexaenoic acid, DHA and eicosapentaenoic acid (EPA)), uridine (as uridine monophosphate (UMP)) and choline, together with phospholipids and B vitamins. Whilst such nutrients are naturally present in food, such levels are difficult to achieve from diet alone.

The safety and efficacy of Souvenaid has been studied in several clinical trials.7,15,16 A further study in prodromal (non-symptomatic Alzheimer's disease) is currently underway. This trial is wholly funded by the European Union.17

Please visit http://www.souvenaid.com for more information.

References

1. Alzheimer's Society. Statistics [Online] http://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID=341 [Accessed December 2012].

2. Jicha GA, Markesbery WR. Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging. 2010;5:45-61.

3. Smach MA, Jacob N, Golmard J-L et al. Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur. Neurol. 2011;65(5):270-8.

4. Glasø M, Nordbø G, Diep L, Bøhmer T. Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease. J Nutr Health Aging. 2004;8(5):407-13.

5. Lopes da Silva S, Elemans S et al. Plasma nutrient status of Alzheimer's disease patients compared to cognitive intact elderly controls; a systematic review and meta-analysis. Alzheimers Dement 2012; 8(4):Supple 2 216.

6. Sijben J, Olde Rikkert MG et al. Different nutritional status in patients with mild Alzheimer's disease compared to healthy controls. Eur J Neurol 2012; in press.

7. Scheltens P, Twisk JW, Blesa R et al. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J  Alzheimers Dis. 2012; 31:225-36.

8. Morris MC, Evans DA, Bienias JL et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol. 2003; 60(7):940-6.

9. Sydenham E, Dangour AD, Lim W-S. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev. 2012; 6:CD005379.

10. Gu Y, Nieves JW, Stern Y et al. Food combination and Alzheimer disease risk: a protective diet. Arch. Neurol. 2010; 67(6):699-706.

11. Zandi PP, Anthony JC, Khachaturian AS et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch. Neurol. 2004; 61(1):82-8.

12. Quadri P, Fragiacomo C, Pezzati R et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr. 2004; 80(1):114-122.

13. Sachdev PS. Homocysteine and brain atrophy. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2005; 29(7):1152-1161.

14. 100 specialists were surveyed online. Fieldwork was conducted by MedeConnect Healthcare Insight 2-16 November 2012.

15. Scheltens P, Kamphuis PJ, Verhey F et al. Efficacy of a medical food in mild Alzheimer's Disease: a randomized controlled trial.

Alzheimer's & Dementia. 2010;6:1-10.

16. Shah R et al. Souvenaid® as an add-on intervention in patients with mild to moderate Alzheimer's disease using Alzheimer's disease medication: results from a randomized, controlled, double-blind study (S-Connect). CTAD, San Diego, November 2011; J Nutr Health Aging (Nov suppl.).

17. European Commission website. LipiDiDiet: http:ec.europa.eu/research/bioeconomy/lipidiet_en.htm [Accessed December 2012].

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software in the hope of capturing value in IoT. Although IoT is relatively new in the market, it has already gone through many promotional terms such as IoE, IoX, SDX, Edge/Fog, Mist Compute, etc. Ultimately, irrespective of the name, it is about deriving value from independent software assets participating in an ecosystem as one comprehensive solution.
SYS-CON Events announced today that A&I Solutions has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 1999, A&I Solutions is a leading information technology (IT) software and services provider focusing on best-in-class enterprise solutions. By partnering with industry leaders in technology, A&I assures customers high performance levels across all IT environments including: mai...
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @ThingsExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
Five years ago development was seen as a dead-end career, now it’s anything but – with an explosion in mobile and IoT initiatives increasing the demand for skilled engineers. But apart from having a ready supply of great coders, what constitutes true ‘DevOps Royalty’? It’ll be the ability to craft resilient architectures, supportability, security everywhere across the software lifecycle. In his keynote at @DevOpsSummit at 20th Cloud Expo, Jeffrey Scheaffer, GM and SVP, Continuous Delivery Busine...
SYS-CON Events announced today that Progress, a global leader in application development, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Enterprises today are rapidly adopting the cloud, while continuing to retain business-critical/sensitive data inside the firewall. This is creating two separate data silos – one inside the firewall and the other outside the firewall. Cloud ISVs ofte...
SYS-CON Events announced today that Systena America will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Systena Group has been in business for various software development and verification in Japan, US, ASEAN, and China by utilizing the knowledge we gained from all types of device development for various industries including smartphones (Android/iOS), wireless communication, security technology and IoT serv...
DevOps at Cloud Expo – being held October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real r...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend @CloudExpo | @ThingsExpo, June 6-8, 2017, at the Javits Center in New York City, NY and October 31 - November 2, 2017, Santa Clara Convention Center, CA. Learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
SYS-CON Events announced today that Super Micro Computer, Inc., a global leader in compute, storage and networking technologies, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Supermicro (NASDAQ: SMCI), the leading innovator in high-performance, high-efficiency server technology, is a premier provider of advanced server Building Block Solutions® for Data Center, Cloud Computing, Enterprise IT, Hadoop/...
SYS-CON Events announced today that CollabNet, a global leader in enterprise software development, release automation and DevOps solutions, will be a Bronze Sponsor of SYS-CON's 20th International Cloud Expo®, taking place from June 6-8, 2017, at the Javits Center in New York City, NY. CollabNet offers a broad range of solutions with the mission of helping modern organizations deliver quality software at speed. The company’s latest innovation, the DevOps Lifecycle Manager (DLM), supports Value S...
Cloud promises the agility required by today’s digital businesses. As organizations adopt cloud based infrastructures and services, their IT resources become increasingly dynamic and hybrid in nature. Managing these require modern IT operations and tools. In his session at 20th Cloud Expo, Raj Sundaram, Senior Principal Product Manager at CA Technologies, will discuss how to modernize your IT operations in order to proactively manage your hybrid cloud and IT environments. He will be sharing bes...
SYS-CON Events announced today that Twistlock, the leading provider of cloud container security solutions, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Twistlock is the industry's first enterprise security suite for container security. Twistlock's technology addresses risks on the host and within the application of the container, enabling enterprises to consistently enforce security policies, monitor...
SYS-CON Events announced today that Peak 10, Inc., a national IT infrastructure and cloud services provider, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Peak 10 provides reliable, tailored data center and network services, cloud and managed services. Its solutions are designed to scale and adapt to customers’ changing business needs, enabling them to lower costs, improve performance and focus intern...
While some vendors scramble to create and sell you a fancy solution for monitoring your spanking new Amazon Lambdas, hear how you can do it on the cheap using just built-in Java APIs yourself. By exploiting a little-known fact that Lambdas aren’t exactly single threaded, you can effectively identify hot spots in your serverless code. In his session at 20th Cloud Expo, David Martin, Principal Product Owner at CA Technologies, will give a live demonstration and code walkthrough, showing how to ov...